Dr. Ibrahim is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
350 Engle St
2 E
Englewood, NJ 07631Phone+1 201-227-5526Fax+1 201-503-1029
Education & Training
Icahn School of Medicine at Mount SinaiResidency, Medical Genetics and Genomics, 1998 - 2000
New York Presbyterian Hospital (Cornell Campus)Residency, Pediatrics, 1995 - 1998
Rutgers New Jersey Medical SchoolClass of 1995
Certifications & Licensure
NJ State Medical License 2000 - 2023
Clinical Trials
Publications & Presentations
PubMed
- 4 citationsEffects of paroxetine, ketoconazole, and rifampin on the metabolism of eliglustat, an oral substrate reduction therapy for Gaucher disease type 1.Lucie Vu, Gerald F. Cox, Jennifer Ibrahim, M. Judith Peterschmitt, Leorah Ross
Molecular Genetics and Metabolism Reports. 2020-01-21 - 36 citationsA pooled analysis of adverse events in 393 adults with Gaucher disease type 1 from four clinical trials of oral eliglustat: Evaluation of frequency, timing, and durationM. Judith Peterschmitt, Gerald F. Cox, Jennifer Ibrahim, James MacDougall, Lisa H. Underhill
Blood Cells, Molecules & Diseases. 2018-02-01 - Letter to the Editor on "Enzyme Replacement or Substrate Reduction? A Review of Gaucher Disease Treatment Options".Jennifer Ibrahim, Rebecca Call
Hospital Pharmacy. 2017-10-10
Press Mentions
Some Students Pushing Back After Temple University Announces Ban on Using Tobacco Products on CampusApril 2nd, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
